{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:35:54Z","timestamp":1791916554627,"version":"4.3.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T00:00:00Z","timestamp":1532044800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s11427-018-9324-y","type":"journal-article","created":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T11:27:07Z","timestamp":1532690827000},"page":"999-1009","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Cryptotanshinone suppresses key onco-proliferative and drug-resistant pathways of chronic myeloid leukemia by targeting STAT5 and STAT3 phosphorylation"],"prefix":"10.1007","volume":"61","author":[{"given":"Bowen","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zirui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhirong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianghu","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,20]]},"reference":[{"key":"9324_CR1","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nature18288","volume":"534","author":"S.A. Abraham","year":"2016","unstructured":"Abraham, S.A., Hopcroft, L.E.M., Carrick, E., Drotar, M.E., Dunn, K., Williamson, A.J.K., Korfi, K., Baquero, P., Park, L.E., Scott, M.T., et al. (2016). Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells. Nature 534, 341\u2013346.","journal-title":"Nature"},{"key":"9324_CR2","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1126\/science.8153630","volume":"264","author":"D.E.H. Afar","year":"1994","unstructured":"Afar, D.E.H., Goga, A., McLaughlin, J., Witte, O.N., and Sawyers, C.L. (1994). Differential complementation of Bcr-Abl point mutants with c-Myc. Science 264, 424\u2013426.","journal-title":"Science"},{"key":"9324_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s12576-015-0410-7","volume":"66","author":"Z. Ahmad","year":"2016","unstructured":"Ahmad, Z., Ng, C.T., Fong, L.Y., Bakar, N.A.A., Hussain, N.H.M., Ang, K. P., Ee, G.C.L., and Hakim, M.N. (2016). Cryptotanshinone inhibits TNF-a-induced early atherogenic events in vitro. J Physiol Sci 66, 213\u2013220.","journal-title":"J Physiol Sci"},{"key":"9324_CR4","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/541144a","volume":"541","author":"M. Baker","year":"2017","unstructured":"Baker, M. (2017). Deceptive curcumin offers cautionary tale for chemists. Nature 541, 144\u2013145.","journal-title":"Nature"},{"key":"9324_CR5","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1126\/science.3460176","volume":"233","author":"Y. Ben-Neriah","year":"1986","unstructured":"Ben-Neriah, Y., Daley, G.Q., Mes-Masson, A.M., Witte, O.N., and Baltimore, D. (1986). The chronic myelogenous leukemia-specific P210 protein is the product of the bcr\/abl hybrid gene. Science 233, 212\u2013214.","journal-title":"Science"},{"key":"9324_CR6","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1158\/1535-7163.MCT-08-0314","volume":"7","author":"N.N. Bewry","year":"2008","unstructured":"Bewry, N.N., Nair, R.R., Emmons, M.F., Boulware, D., Pinilla-Ibarz, J., and Hazlehurst, L.A. (2008). Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance. Mol Cancer Therapeut 7, 3169\u20133175.","journal-title":"Mol Cancer Therapeut"},{"key":"9324_CR7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3324\/haematol.2013.098442","volume":"99","author":"S. Bibi","year":"2014","unstructured":"Bibi, S., Arslanhan, M.D., Langenfeld, F., Jeanningros, S., Cerny-Reiterer, S., Hadzijusufovic, E., Tchertanov, L., Moriggl, R., Valent, P., and Arock, M. (2014). Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy. Haematologica 99, 417\u2013429.","journal-title":"Haematologica"},{"key":"9324_CR8","doi-asserted-by":"publisher","first-page":"14895","DOI":"10.3748\/wjg.v20.i40.14895","volume":"20","author":"R.Y. Chen","year":"2014","unstructured":"Chen, R.Y., Xu, B., Chen, S.F., Chen, S.S., Zhang, T., Ren, J., and Xu, J. (2014). Effect of oridonin-mediated hallmark changes on inflammatory pathways in human pancreatic cancer (BxPC-3) cells. World J Gastroenterol 20, 14895\u201314903.","journal-title":"World J Gastroenterol"},{"key":"9324_CR9","doi-asserted-by":"publisher","first-page":"979","DOI":"10.2174\/18715206113139990115","volume":"13","author":"W. Chen","year":"2013","unstructured":"Chen, W., Lu, Y., Chen, G., and Huang, S. (2013). Molecular evidence of cryptotanshinone for treatment and prevention of human cancer. Anticancer Agents Med Chem 13, 979\u2013987.","journal-title":"Anticancer Agents Med Chem"},{"key":"9324_CR10","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.1200\/JCO.2007.15.8154","volume":"26","author":"H. Lavallade de","year":"2008","unstructured":"de Lavallade, H., Apperley, J.F., Khorashad, J.S., Milojkovic, D., Reid, A. G., Bua, M., Szydlo, R., Olavarria, E., Kaeda, J., Goldman, J.M., et al. (2008). Imatinib for newly diagnosed patients with chronic myeloid leukemia: incidence of sustained responses in an intention-to-treat analysis. J Clin Oncol 26, 3358\u20133363.","journal-title":"J Clin Oncol"},{"key":"9324_CR11","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1038\/leusup.2014.3","volume":"3","author":"A.M. Eiring","year":"2014","unstructured":"Eiring, A.M., Kraft, I.L., Page, B.D., O\u2019Hare, T., Gunning, P.T., and Deininger, M.W. (2014). STAT3 as a mediator of BCR-ABL1-independent resistance in chronic myeloid leukemia. Leukemia Suppl 3, S5\u2013S6.","journal-title":"Leukemia"},{"key":"9324_CR12","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1242\/jcs.119214","volume":"126","author":"H.S. Elsarraj","year":"2013","unstructured":"Elsarraj, H.S., Hong, Y., Valdez, K., Carletti, M., Salah, S.M., Raimo, M., Taverna, D., Prochasson, P., Bharadwaj, U., Tweardy, D.J., et al. (2013). A novel role of microRNA146b in promoting mammary alveolar progenitor cell maintenance. J Cell Sci 126, 2446\u20132458.","journal-title":"J Cell Sci"},{"key":"9324_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.tox.2012.05.024","volume":"300","author":"S. Finaurini","year":"2012","unstructured":"Finaurini, S., Basilico, N., Corbett, Y., D\u2019Alessandro, S., Parapini, S., Olliaro, P., Haynes, R.K., and Taramelli, D. (2012). Dihydroartemisinin inhibits the human erythroid cell differentiation by altering the cell cycle. Toxicology 300, 57\u201366.","journal-title":"Toxicology"},{"key":"9324_CR14","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s12013-014-0244-6","volume":"71","author":"A. Gheysarzadeh","year":"2015","unstructured":"Gheysarzadeh, A., and Yazdanparast, R. (2015). STAT5 reactivation by catechin modulates H2O2-induced apoptosis through miR-182\/FOXO1 pathway in SK-N-MC cells. Cell Biochem Biophys 71, 649\u2013656.","journal-title":"Cell Biochem Biophys"},{"key":"9324_CR15","doi-asserted-by":"publisher","first-page":"132","DOI":"10.2174\/1389202917666160803150639","volume":"18","author":"L.M. Guam\u00e1n-Ortiz","year":"2017","unstructured":"Guam\u00e1n-Ortiz, L.M., Orellana, M.I.R., and Ratovitski, E.A. (2017). Natural compounds as modulators of non-apoptotic cell death in cancer cells. Curr Genomics 18, 132\u2013155.","journal-title":"Curr Genomics"},{"key":"9324_CR16","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nchembio.775","volume":"8","author":"O. Hantschel","year":"2012","unstructured":"Hantschel, O., Warsch, W., Eckelhart, E., Kaupe, I., Grebien, F., Wagner, K. U., Superti-Furga, G., and Sexl, V. (2012). BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia. Nat Chem Biol 8, 285\u2013293.","journal-title":"Nat Chem Biol"},{"key":"9324_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/543040c","volume":"543","author":"M. Heger","year":"2017","unstructured":"Heger, M. (2017). Don\u2019t discount all curcumin trial data. Nature 543, 40.","journal-title":"Nature"},{"key":"9324_CR18","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/leu.2009.38","volume":"23","author":"A. Hochhaus","year":"2009","unstructured":"Hochhaus, A., O\u2019Brien, S.G., Guilhot, F., Druker, B.J., Branford, S., Foroni, L., Goldman, J.M., M\u00fcller, M.C., Radich, J.P., Rudoltz, M., et al. (2009). Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia. Leukemia 23, 1054\u20131061.","journal-title":"Leukemia"},{"key":"9324_CR19","doi-asserted-by":"publisher","first-page":"41525","DOI":"10.1038\/srep41525","volume":"7","author":"H. Huang","year":"2017","unstructured":"Huang, H., Weng, H., Dong, B., Zhao, P., Zhou, H., and Qu, L. (2017). Oridonin triggers chaperon-mediated proteasomal degradation of BCRABL in leukemia. Sci Rep 7, 41525.","journal-title":"Sci Rep"},{"key":"9324_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/476974","volume":"2014","author":"K. Katayama","year":"2014","unstructured":"Katayama, K., Noguchi, K., and Sugimoto, Y. (2014). Regulations of Pglycoprotein\/ABCB1\/MDR1 in human cancer cells. New J Sci 2014, 1\u201310.","journal-title":"New J Sci"},{"key":"9324_CR21","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1038\/nm1135","volume":"10","author":"W. Kong","year":"2004","unstructured":"Kong, W., Wei, J., Abidi, P., Lin, M., Inaba, S., Li, C., Wang, Y., Wang, Z., Si, S., Pan, H., et al. (2004). Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 10, 1344\u20131351.","journal-title":"Nat Med"},{"key":"9324_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1586\/14737159.8.1.73","volume":"8","author":"R.S. Lewis","year":"2008","unstructured":"Lewis, R.S., and Ward, A.C. (2008). Stat5 as a diagnostic marker for leukemia. Expert Rev Mol Diagnost 8, 73\u201382.","journal-title":"Expert Rev Mol Diagnost"},{"key":"9324_CR23","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1182\/blood-2009-07-234963","volume":"115","author":"G. Li","year":"2010","unstructured":"Li, G., Miskimen, K.L., Wang, Z., Xie, X.Y., Brenzovich, J., Ryan, J.J., Tse, W., Moriggl, R., and Bunting, K.D. (2010). STAT5 requires the Ndomain for suppression of miR15\/16, induction of bcl-2, and survival signaling in myeloproliferative disease. Blood 115, 1416\u20131424.","journal-title":"Blood"},{"key":"9324_CR24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/1042819031000139710","volume":"45","author":"Y.J. Lou","year":"2004","unstructured":"Lou, Y.J., and Jin, J. (2004). Triptolide down-regulates bcr-abl expression and induces apoptosis in chronic myelogenous leukemia cells. Leukemia Lymphoma 45, 373\u2013376.","journal-title":"Leukemia Lymphoma"},{"key":"9324_CR25","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.gpb.2018.03.002","volume":"16","author":"L. Ma","year":"2018","unstructured":"Ma, L., Liang, Z., Zhou, H., and Qu, L. (2018). Applications of RNA indexes for precision oncology in breast cancer. Genomics Proteomics Bioinformatics 16, 108\u2013119.","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"9324_CR26","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jep.2016.05.018","volume":"188","author":"S. Ma","year":"2016","unstructured":"Ma, S., Zhang, D., Lou, H., Sun, L., and Ji, J. (2016). Evaluation of the anti-inflammatory activities of tanshinones isolated from Salvia miltiorrhiza var. alba roots in THP-1 macrophages. J Ethnopharmacol 188, 193\u2013199.","journal-title":"J Ethnopharmacol"},{"key":"9324_CR27","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1038\/cdd.2011.77","volume":"18","author":"J.R. Matthews","year":"2011","unstructured":"Matthews, J.R., Sansom, O.J., and Clarke, A.R. (2011). Absolute requirement for STAT3 function in small-intestine crypt stem cell survival. Cell Death Differ 18, 1934\u20131943.","journal-title":"Cell Death Differ"},{"key":"9324_CR28","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrd4088","volume":"12","author":"G. Miklossy","year":"2013","unstructured":"Miklossy, G., Hilliard, T.S., and Turkson, J. (2013). Therapeutic modulators of STAT signalling for human diseases. Nat Rev Drug Discov 12, 611\u2013629.","journal-title":"Nat Rev Drug Discov"},{"key":"9324_CR29","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2741\/1791","volume":"11","author":"T.I. Mughal","year":"2006","unstructured":"Mughal, T.I., and Goldman, J.M. (2006). Chronic myeloid leukemia: why does it evolve from chronic phase to blast transformation? Front Biosci 11, 198\u2013208.","journal-title":"Front Biosci"},{"key":"9324_CR30","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nature03677","volume":"435","author":"K.A. O\u2019Donnell","year":"2005","unstructured":"O\u2019Donnell, K.A., Wentzel, E.A., Zeller, K.I., Dang, C.V., and Mendell, J.T. (2005). c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435, 839\u2013843.","journal-title":"Nature"},{"key":"9324_CR31","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrc3317","volume":"12","author":"T. O\u2019Hare","year":"2012","unstructured":"O\u2019Hare, T., Zabriskie, M.S., Eiring, A.M., and Deininger, M.W. (2012). Pushing the limits of targeted therapy in chronic myeloid leukaemia. Nat Rev Cancer 12, 513\u2013526.","journal-title":"Nat Rev Cancer"},{"key":"9324_CR32","doi-asserted-by":"publisher","first-page":"142","DOI":"10.2741\/s257","volume":"S4","author":"L. Pan","year":"2012","unstructured":"Pan, L., Chai, H.B., and Kinghorn, A.D. (2012). Discovery of new anticancer agents from higher plants. Front Biosci S4, 142\u2013156.","journal-title":"Front Biosci"},{"key":"9324_CR33","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s12032-010-9586-0","volume":"28","author":"Y. Pazhang","year":"2011","unstructured":"Pazhang, Y., Ahmadian, S., Mahmoudian, M., and Shafiezadeh, M. (2011). Berberine-induced apoptosis via decreasing the survivin protein in K-562 cell line. Med Oncol 28, 1577\u20131583.","journal-title":"Med Oncol"},{"key":"9324_CR34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12867-016-0063-y","volume":"17","author":"S. Pinz","year":"2016","unstructured":"Pinz, S., Unser, S., and Rascle, A. (2016). Signal transducer and activator of transcription STAT5 is recruited to c-Myc super-enhancer. BMC Mol Biol 17, 10.","journal-title":"BMC Mol Biol"},{"key":"9324_CR35","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1111\/jcmm.13170","volume":"21","author":"Y. Qu","year":"2017","unstructured":"Qu, Y., Zhang, Q., Cai, X., Li, F., Ma, Z., Xu, M., and Lu, L. (2017). Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation. J Cell Mol Med 21, 2491\u20132502.","journal-title":"J Cell Mol Med"},{"key":"9324_CR36","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nrc1567","volume":"5","author":"R. Ren","year":"2005","unstructured":"Ren, R. (2005). Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer 5, 172\u2013183.","journal-title":"Nat Rev Cancer"},{"key":"9324_CR37","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/243290a0","volume":"243","author":"J.D. Rowley","year":"1973","unstructured":"Rowley, J.D. (1973). A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243, 290\u2013293.","journal-title":"Nature"},{"key":"9324_CR38","doi-asserted-by":"publisher","first-page":"5261","DOI":"10.1038\/onc.2012.621","volume":"32","author":"V.J. Sanchez-Ar\u00e9valo Lobo","year":"2013","unstructured":"Sanchez-Ar\u00e9valo Lobo, V.J., Doni, M., Verrecchia, A., Sanulli, S., Fag\u00e0, G., Piontini, A., Bianchi, M., Conacci-Sorrell, M., Mazzarol, G., Peg, V., et al. (2013). Dual regulation of Myc by Abl. Oncogene 32, 5261\u20135271.","journal-title":"Oncogene"},{"issue":"1","key":"9324_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3109\/10428199309047862","volume":"11","author":"C.L. Sawyers","year":"1993","unstructured":"Sawyers, C.L. (1993). The role of myc in transformation by BCR-ABL. Leukemia Lymphoma 11 Suppl 1, 45\u201346.","journal-title":"Leukemia Lymphoma"},{"key":"9324_CR40","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/0092-8674(92)90241-4","volume":"70","author":"C.L. Sawyers","year":"1992","unstructured":"Sawyers, C.L., Callahan, W., and Witte, O.N. (1992). Dominant negative MYC blocks transformation by ABL oncogenes. Cell 70, 901\u2013910.","journal-title":"Cell"},{"key":"9324_CR41","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1158\/0008-5472.CAN-08-2575","volume":"69","author":"D.S. Shin","year":"2009","unstructured":"Shin, D.S., Kim, H.N., Shin, K.D., Yoon, Y.J., Kim, S.J., Han, D.C., and Kwon, B.M. (2009). Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells. Cancer Res 69, 193\u2013202.","journal-title":"Cancer Res"},{"key":"9324_CR42","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/315550a0","volume":"315","author":"E. Shtivelman","year":"1985","unstructured":"Shtivelman, E., Lifshitz, B., Gale, R.P., and Canaani, E. (1985). Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature 315, 550\u2013554.","journal-title":"Nature"},{"key":"9324_CR43","first-page":"247","volume":"13","author":"K. Shuai","year":"1996","unstructured":"Shuai, K., Halpern, J., ten Hoeve, J., Rao, X., and Sawyers, C.L. (1996). Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia. Oncogene 13, 247\u2013254.","journal-title":"Oncogene"},{"key":"9324_CR44","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1186\/1471-2407-13-619","volume":"13","author":"C.M. Tsang","year":"2013","unstructured":"Tsang, C.M., Cheung, Y.C., Lui, V.W.Y., Yip, Y.L., Zhang, G., Lin, V.W., Cheung, K.C.P., Feng, Y., and Tsao, S.W. (2013). Berberine suppresses tumorigenicity and growth of nasopharyngeal carcinoma cells by inhibiting STAT3 activation induced by tumor associated fibroblasts. BMC Cancer 13, 619.","journal-title":"BMC Cancer"},{"key":"9324_CR45","first-page":"682","volume":"77","author":"T. Tsuruo","year":"1986","unstructured":"Tsuruo, T., Iida-Saito, H., Kawabata, H., Oh-hara, T., Hamada, H., and Utakoji, T. (1986). Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones. Jap J Cancer Res 77, 682\u2013692.","journal-title":"Jap J Cancer Res"},{"key":"9324_CR46","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/cyto.b.20580","volume":"80B","author":"F.C. Vasconcelos","year":"2011","unstructured":"Vasconcelos, F.C., Silva, K.L., Souza, P.S., Silva, L.F.R., Moellmann-Coelho, A., Klumb, C.E., and Maia, R.C. (2011). Variation of MDR proteins expression and activity levels according to clinical status and evolution of CML patients. Cytometry 80B, 158\u2013166.","journal-title":"Cytometry"},{"key":"9324_CR47","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.4161\/cc.25116","volume":"12","author":"W. Warsch","year":"2013","unstructured":"Warsch, W., Grundschober, E., and Sexl, V. (2013). Adding a new facet to STAT5 in CML: multitasking for leukemic cells. Cell Cycle 12, 1813\u20131814.","journal-title":"Cell Cycle"},{"key":"9324_CR48","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.1158\/0008-5472.CAN-13-1748","volume":"74","author":"H. Weng","year":"2014","unstructured":"Weng, H., Huang, H., Dong, B., Zhao, P., Zhou, H., and Qu, L. (2014). Inhibition of miR-17 and miR-20a by oridonin triggers apoptosis and reverses chemoresistance by derepressing BIM-S. Cancer Res 74, 4409\u20134419.","journal-title":"Cancer Res"},{"key":"9324_CR49","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.mvr.2016.12.011","volume":"111","author":"X. Xu","year":"2017","unstructured":"Xu, X., Wu, L., Zhou, X., Zhou, N., Zhuang, Q., Yang, J., Dai, J., Wang, H., Chen, S., and Mao, W. (2017). Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway. Microvasc Res 111, 25\u201331.","journal-title":"Microvasc Res"},{"key":"9324_CR50","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.bcp.2018.01.031","volume":"150","author":"X. Yan","year":"2018","unstructured":"Yan, X., Li, P., Zhan, Y., Qi, M., Liu, J., An, Z., Yang, W., Xiao, H., Wu, H., Qi, Y., et al. (2018). Dihydroartemisinin suppresses STAT3 signaling and Mcl-1 and survivin expression to potentiate ABT-263-induced apoptosis in non-small cell lung cancer cells harboring EGFR or RAS mutation. Biochem Pharmacol 150, 72\u201385.","journal-title":"Biochem Pharmacol"},{"key":"9324_CR51","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3109\/1061186X.2013.830309","volume":"21","author":"S. Yang","year":"2013","unstructured":"Yang, S., Wang, P., Wang, X., Zhang, K., Zhang, X., and Liu, Q. (2013). Efficacy of combined therapy with paclitaxel and low-level ultrasound in human chronic myelogenous leukemia cell line K562. J Drug Targeting 21, 874\u2013884.","journal-title":"J Drug Targeting"},{"key":"9324_CR52","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.bbrc.2016.03.141","volume":"473","author":"J. Yao","year":"2016","unstructured":"Yao, J., Wei, X., and Lu, Y. (2016). Chaetominine reduces MRP1-mediated drug resistance via inhibiting PI3K\/Akt\/Nrf2 signaling pathway in K-562\/Adr human leukemia cells. Biochem Biophys Res Commun 473, 867\u2013873.","journal-title":"Biochem Biophys Res Commun"},{"key":"9324_CR53","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrc1275","volume":"4","author":"H. Yu","year":"2004","unstructured":"Yu, H., and Jove, R. (2004). The STATs of cancer\u2014new molecular targets come of age. Nat Rev Cancer 4, 97\u2013105.","journal-title":"Nat Rev Cancer"},{"key":"9324_CR54","doi-asserted-by":"publisher","first-page":"13812","DOI":"10.1074\/jbc.M115.653261","volume":"290","author":"W. Zhang","year":"2015","unstructured":"Zhang, W., Qian, P., Zhang, X., Zhang, M., Wang, H., Wu, M., Kong, X., Tan, S., Ding, K., Perry, J.K., et al. (2015). Autocrine\/paracrine human growth hormone-stimulated microRNA 96-182-183 cluster promotes epithelial-mesenchymal transition and invasion in breast cancer. J Biol Chem 290, 13812\u201313829.","journal-title":"J Biol Chem"},{"key":"9324_CR55","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/15384047.2016.1276129","volume":"18","author":"Y. Zhang","year":"2017","unstructured":"Zhang, Y., Kong, Y., Liu, S., Zeng, L., Wan, L., and Zhang, Z. (2017). Curcumin induces apoptosis in human leukemic cell lines through an IFIT2-dependent pathway. Cancer Biol Ther 18, 43\u201350.","journal-title":"Cancer Biol Ther"},{"key":"9324_CR56","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.3390\/molecules16032259","volume":"16","author":"J. Zhao","year":"2011","unstructured":"Zhao, J., Lou, J., Mou, Y., Li, P., Wu, J., and Zhou, L. (2011). Diterpenoid tanshinones and phenolic acids from cultured hairy roots of Salvia miltiorrhiza Bunge and their antimicrobial activities. Molecules 16, 2259\u20132267.","journal-title":"Molecules"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11427-018-9324-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-018-9324-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-018-9324-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T23:25:03Z","timestamp":1563578703000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11427-018-9324-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,20]]},"references-count":56,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["9324"],"URL":"https:\/\/doi.org\/10.1007\/s11427-018-9324-y","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,20]]},"assertion":[{"value":"4 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}